Access to Medicines
Keeping It Real - Protecting the world's poor from fake drugs
Martes, Mayo 5, 2009
How to Worsen Africa's Health Crisis
IPN Opinion article
Killing off drug patents will kill off innovation and patients.
AP: Africans text message to check if drugs are real
IPN News coverage
Julian Harris comments on a technological solution to the fake drug problem in Africa.
Wrong Tax, Wrong Disease
IPN Opinion article
Officials and activists (and a slightly equivocal Bill Clinton) at the recent world AIDS conference in Vienna want a "Robin Hood" tax on financial transactions to fund HIV/AIDS relief. This well-published analyst explains why this is a bad and counter-productive idea.
What Purpose Unitaid’s Patent Pool?
Miércoles, Junio 16, 2010
This paper examines the wisdom of Unitaid's new patent pool for AIDS treatments, considering the weaknesses in the case for such a pool, the lessons from historical examples and the likely consequences for research and development.
Producing Medicines for Chronic Diseases in Less Developed Countries
Jueves, Junio 10, 2010
The HIV / AIDS crisis bears a number of clinical and practical similarities to the new challenge of producing drugs to treating chronic disease in lower-income countries, providing a useful case study when determining effective strategies. A new literature review by Philip Stevens, the second in a three-part series, examines what can be learned from the global response to HIV / AIDS – and reveals some costly mistakes that should not be repeated.
Report Calls Tuberculosis 'Neglected Sister'
IPN News coverage
Philip Stevens discusses how best to support tuberculosis patients in the developing world.
The new boom in malaria
World Malaria Day, 25 April - The biggest threat is the rise of drug-resistant parasites due to fake and sub-standard medicines. As with other drugs before, this resistance is emerging all along the Mekong, from Cambodia to Myanmar, where the wonder-drug artemisinin is already failing: this threatens malaria victims everywhere.
